Phase II trial of oral altretamine for relapsed ovarian carcinoma: evaluation of defining response by serum CA125 (Q71975331)
Jump to navigation
Jump to search
scientific article published on 01 January 1997
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II trial of oral altretamine for relapsed ovarian carcinoma: evaluation of defining response by serum CA125 |
scientific article published on 01 January 1997 |
Statements
Phase II trial of oral altretamine for relapsed ovarian carcinoma: evaluation of defining response by serum CA125 (English)
G J Rustin
A E Nelstrop
M Crawford
J Ledermann
H E Lambert
R Coleman
J Johnson
H Evans
S Brown